Metabolomics Workbench : NIH Data Repository : Analyze Studies

Data for ST001140

(Analysis AN001870): Average values per metabolite and experimental factor (Units:uM)

Metabolite structure	F1	F2	F3	F4
CE(16:0)	2.67	2.94	2.03	1.56
CE(16:1)	0.47	0.52	0.44	0.37
CE(17:0)	0.06	0.06	0.05	0.03
CE(17:1)	0.05	0.06	0.06	0.05
CE(18:0)	0.52	0.66	0.46	0.38
CE(18:1)	22.69	22.21	22.53	20.25
CE(18:2)	85.96	85.68	95.16	74.09
CE(18:3)	0.94	1.40	1.73	0.94
CE(20:1)	0.02	0.03	0.02	0.03
CE(20:2)	0.14	0.15	0.14	0.16
CE(20:3)	1.85	1.71	2.01	2.74
CE(20:4)	64.13	55.53	69.66	33.14
CE(20:5)	0.75	2.90	1.15	0.96
CE(22:4)	0.34	0.43	0.38	0.16
CE(22:5)	0.68	0.63	1.02	0.40
CE(22:6)	0.57	0.88	1.04	0.49
CE(24:4)	0.01	0.02	-	-
DG(16:0_20:4)	13.52	12.34	4.82	7.27
DG(18:0_18:2)	11.83	15.44	3.65	21.63
DG(18:0_20:4)	12.14	12.59	7.63	11.30
DG(18:1_18:2)	-	-	34.63	112.54
DG(18:1_20:4)	24.97	13.45	16.01	18.52
DG(18:2_18:2)	12.63	16.09	-	-
DG(18:2_20:4)	15.22	11.26	12.68	9.84
LPC(14:0)	0.93	0.86	0.59	0.73
LPC(15:0)	0.54	0.57	0.43	0.54
LPC(16:0)	88.35	101.05	71.57	107.51
LPC(16:1)	4.22	3.93	3.61	4.34
LPC(17:0)	2.68	2.07	2.05	2.06
LPC(17:1)	0.28	0.33	0.23	0.35
LPC(18:0)	128.08	109.76	138.75	120.37
LPC(18:1)	37.33	37.93	30.55	39.40
LPC(18:2)	57.80	66.44	44.85	81.08
LPC(18:3)	0.53	0.75	0.49	0.85
LPC(19:0)	0.94	0.45	0.64	0.27
LPC(20:1)	0.59	0.58	0.60	0.48
LPC(20:2)	0.62	0.64	0.55	0.70
LPC(20:3)	2.96	3.13	2.78	6.54
LPC(20:4)	35.19	33.55	35.73	22.89
LPC(20:5)	0.30	2.14	0.44	0.48
LPC(22:0)	0.11	0.08	0.09	0.05
LPC(22:1)	0.14	0.14	0.15	0.11
LPC(22:5)	2.71	2.65	3.99	2.34
LPC(22:6)	0.51	1.28	0.74	0.63
LPC(24:0)	0.13	0.12	0.11	0.06
LPC(O-16:0)	1.17	1.40	1.26	0.68
LPC(O-18:0)	0.50	0.56	0.59	0.39
LPC(O-18:1)	1.27	1.45	1.33	0.81
LPC(O-20:0)	0.04	0.03	0.05	0.02
LPC(O-20:1)	0.03	0.04	0.04	0.02
LPE(16:0)	2.26	3.29	2.29	2.27
LPE(18:0)	7.81	10.56	6.75	8.49
LPE(18:1)	3.26	3.82	2.57	2.93
LPE(18:2)	3.81	3.58	2.56	5.22
LPE(20:4)	1.77	1.80	1.39	1.77
PC(29:0)	0.04	0.03	0.04	0.03
PC(31:0)	0.20	0.22	0.18	0.13
PC(31:1)	0.10	0.07	0.09	0.09
PC(32:0)	10.87	11.33	8.91	8.50
PC(32:1)	13.50	9.86	11.56	17.06
PC(32:2)	3.77	2.32	2.89	3.72
PC(32:3)	0.07	0.06	0.07	0.08
PC(33:1)	1.42	1.25	1.25	1.84
PC(33:2)	2.49	2.05	2.09	3.44
PC(34:0)	8.88	8.55	6.56	6.92
PC(34:1)	81.42	75.88	75.10	110.46
PC(34:3)	27.76	19.31	25.98	34.38
PC(34:4)	0.90	0.60	0.58	0.53
PC(35:1)	7.28	4.71	5.61	6.68
PC(35:2)	13.13	7.89	9.19	12.96
PC(35:3)	2.05	1.47	1.66	2.84
PC(35:4)	1.22	1.05	0.96	0.79
PC(36:1)	58.15	42.56	62.17	66.75
PC(36:2)	178.70	153.46	154.01	219.25
PC(36:3)	92.27	59.28	77.09	103.30
PC(36:4)	130.95	110.66	122.20	102.21
PC(36:5)	11.72	24.10	10.80	10.05
PC(37:4)	15.39	8.41	14.15	6.88
PC(37:5)	1.97	2.21	1.99	1.42
PC(38:2)	3.10	2.07	3.33	3.56
PC(38:3)	32.19	21.78	37.78	61.94
PC(38:4)	187.97	139.64	197.22	121.79
PC(38:5)	64.52	61.23	76.26	39.96
PC(38:6)	23.71	30.08	25.32	23.05
PC(38:7)	0.90	1.47	1.02	0.95
PC(39:5)	1.36	0.76	1.74	0.72
PC(39:6)	0.18	0.25	0.25	0.15
PC(40:4)	13.86	9.46	15.13	5.68
PC(40:5)	8.23	5.66	13.51	7.21
PC(40:6)	11.91	10.58	18.31	9.50
PC(40:7)	2.43	2.09	2.97	2.47
PC(40:8)	2.04	2.04	2.05	1.13
PC(O-32:0)	2.70	3.85	2.64	1.45
PC(O-32:1)	1.59	1.43	1.76	0.98
PC(O-32:2)	0.18	0.14	0.23	0.11
PC(O-34:1)	10.33	8.37	10.84	6.01
PC(O-34:2)	4.02	3.54	4.70	2.75
PC(O-34:3)	0.24	0.20	0.29	0.18
PC(O-36:2)	2.89	2.51	3.12	2.50
PC(O-36:3)	2.18	2.10	2.26	1.95
PC(O-36:4)	23.44	25.06	27.11	12.50
PC(O-36:5)	1.35	1.60	1.63	0.77
PC(O-38:4)	10.78	12.38	13.60	7.38
PC(O-38:5)	26.74	26.10	29.16	14.37
PC(O-38:6)	1.28	1.49	1.61	0.91
PC(O-40:5)	3.46	3.22	4.64	2.04
PC(O-40:6)	0.95	0.91	1.36	0.78
PC(P-30:0)	0.04	0.04	0.05	0.01
PC(P-32:0)	0.59	0.88	0.69	0.35
PC(P-32:1)	0.19	0.17	0.26	0.11
PC(P-34:1)	2.61	2.26	3.41	1.02
PC(P-34:2)	4.22	3.46	5.56	2.26
PC(P-34:3)	0.25	0.22	0.29	0.12
PC(P-36:2)	1.27	1.08	1.68	0.88
PC(P-36:4)	9.05	9.71	11.20	4.77
PC(P-36:5)	0.23	0.46	0.39	0.22
PC(P-38:4)	2.77	3.27	3.56	2.40
PC(P-38:5)	2.64	2.88	3.70	1.79
PC(P-38:6)	0.40	0.41	0.51	0.32
PE(34:1)	0.34	1.05	0.35	0.57
PE(34:2)	1.57	1.69	1.35	2.60
PE(36:1)	0.89	1.84	0.52	1.00
PE(36:2)	5.66	5.38	3.04	6.51
PE(36:3)	1.81	1.19	1.26	1.86
PE(36:4)	2.12	2.09	1.93	1.78
PE(38:3)	-	-	0.28	0.67
PE(38:4)	11.16	9.12	8.14	8.51
PE(38:5)	2.62	1.93	2.45	1.77
PE(38:6)	0.59	1.14	0.67	0.54
PE(40:4)	0.63	0.45	0.40	0.33
PE(40:5)	1.14	0.71	1.10	0.71
PE(40:6)	0.21	0.46	0.18	0.19
PE(O-18:1/20:3)	0.90	0.85	1.11	0.48
PE(P-16:0/18:1)	0.24	0.38	-	-
PE(P-16:0/20:4)	1.20	1.38	1.32	0.94
PE(P-16:0/22:5)	1.06	1.08	1.39	1.03
PE(P-16:0/22:6)	0.63	1.15	0.88	0.70
PE(P-18:0/18:1)	0.58	0.61	0.54	0.63
PE(P-18:0/18:2)	1.14	1.36	1.08	2.36
PE(P-18:0/20:4)	5.82	6.19	5.89	5.28
PE(P-18:0/22:5)	1.84	1.55	2.06	1.67
PE(P-18:0/22:6)	0.60	0.84	0.78	0.79
PE(P-20:0/20:4)	-	-	0.11	0.10
PI(32:1)	0.64	0.29	0.56	0.46
PI(34:1)	5.33	2.44	4.32	4.49
PI(34:2)	8.31	4.15	6.60	6.95
PI(36:1)	3.09	1.69	2.42	3.62
PI(36:2)	39.53	20.70	25.43	31.23
PI(36:3)	6.94	2.58	4.96	5.85
PI(36:4)	17.91	7.02	12.24	7.29
PI(38:2)	-	-	0.69	2.47
PI(38:3)	7.87	3.63	7.02	12.09
PI(38:4)	201.80	87.76	171.21	110.51
PI(38:5)	11.73	4.28	11.11	4.84
PI(40:4)	1.96	0.96	1.46	1.06
PI(40:5)	7.16	3.08	9.70	5.74
PS(38:4)	0.52	0.39	1.46	0.26

Factors:

F1	TreatmentGroup:Prednisolone \| TreatmentDuration:0d \| SamplingTimePoint:before
F2	TreatmentGroup:Prednisolone \| TreatmentDuration:4d \| SamplingTimePoint:after
F3	TreatmentGroup:Tetracosactide \| TreatmentDuration:00w \| SamplingTimePoint:before
F4	TreatmentGroup:Tetracosactide \| TreatmentDuration:25w \| SamplingTimePoint:after